Common Causes of Drug-Induced Liver Injury in 2025
Abstract
Drug-induced liver injury (DILI) is an important clinical condition and should be considered in the differential diagnosis of patients with elevated liver enzymes and normal hepatobiliary imaging. In previous studies of DILI, antibiotics were the most commonly implicated class of drugs. A newly recognized phenotype of cefazolin has been described in several studies. After an ultra-short duration of cefazolin, with 1 or 2 doses, a prominent cholestatic or mixed reaction develops 2-3 weeks later. This phenotype was originally described in the United States and has recently been reproduced in a study from Iceland. In a recent and important report from Türkiye, hepatocellular jaundice associated with the antibiotic ornidazole was described; 8% of affected patients required liver transplantation. In recent years, several new agents have been associated with other idiosyncratic DILI associated with prescription drugs, suggesting that the clinical landscape of DILI may be evolving. Liver injury resulting from the biological effects of drugs that modulate the immune system appears to be increasing. In a recent study from Barcelona, anticancer drugs, mainly checkpoint inhibitors, were the most frequent causes of DILI, followed by antibiotics, analgesics, and recreational drugs. Furthermore, several newly recognized hepatotoxic herbal and dietary supplements (HDSs) have been reported. These are Polygonum multiflorum, ashwagandha, green tea extract, turmeric, Tinospora cordifolia,…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.